Article
Document
Anualidad
Academic Article
Information Content Entity
Continuant
Entity
Generically Dependent Continuant
Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in "suboptimal" patients with advanced gastric cancer (AGC). TTD 08-02
RDF description of Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in "suboptimal" patients with advanced gastric cancer (AGC). TTD 08-02 - http://research.umh.es/vivo/pub/articulo/161695